NCT00157872View on ClinicalTrials.gov

A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)

PHASE4CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

January 7, 2004

Primary Completion Date

July 5, 2004

Study Completion Date

September 19, 2004

Conditions

Rheumatoid Arthritis

Interventions

DRUG

MK0966; rofecoxib

DRUG

Comparator: naproxen tablet 500 mg

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00157872 - A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231) | Biotech Hunter | Biotech Hunter